Contents
- Why astatine compounds are so hard to study
- Astatides: the simplest compounds
- Interhalogens: AtI, AtBr and AtCl
- Oxygen species and oxidation states
- Organoastatine compounds
- Astatine vs iodine chemistry
- Astatine-211 and targeted alpha therapy
- Summary
Nobody has ever held a visible sample of an astatine compound. The longest-lived isotope, astatine-210, has a half-life of about 8.1 hours, and every atom you make starts decaying immediately. Most of what chemists know about astatine compounds comes from trace amounts, sometimes a few billion atoms, tracked by their radioactivity rather than seen.
That makes this a short list of confirmed compounds and a longer list of educated guesses. This post separates the two.
Why astatine compounds are so hard to study
Astatine is the heaviest halogen that occurs in nature, and it barely occurs at all. The Los Alamos periodic table entry notes that every isotope is radioactive and short-lived, so the element is only ever present in the Earth’s crust as a brief product of uranium and thorium decay.
Labs make it instead. Bombarding bismuth-209 with alpha particles in a cyclotron produces astatine-211 (half-life about 7.2 hours). The result is a nano-scale quantity, far too little to weigh, see or crystallize.
At that scale, normal chemistry rules change. There aren’t enough astatine atoms to form a precipitate of their own, so chemists use iodine as a carrier. If a trace of astatine co-precipitates with silver iodide, it behaves like iodide. If it stays in solution, it doesn’t. Each of those observations is a data point about what astatine can and can’t do, and the whole field is built from such points: extraction behavior, chromatography retention, and co-precipitation.
Relativistic effects add another complication. In an atom this heavy, the inner electrons move fast enough that quantum calculations have to account for it. Many astatine “compounds” in the literature were first predicted by calculation and only later checked in the lab. Some haven’t been checked at all.
Astatides: the simplest compounds
An astatide is astatine in the -1 oxidation state, the same state as chloride or iodide. The evidence for it is real but indirect.
- Hydrogen astatide (HAt): Observed, and weakly bound. The H-At bond is the weakest of any hydrogen halide, so HAt breaks apart easily.
- Silver, palladium, thallium and lead astatides: Astatide co-precipitates with insoluble iodides of these metals, which is how it was identified as a halide ion. Silver astatide (AgAt) is the classic case.
- Sodium astatide (NaAt): Assumed from solution behavior. It is soluble, so it never forms a visible solid.
Astatine also differs from iodine here: it is more metallic, and in some conditions it forms a positive ion (At+) instead of a negative one. That duality is the first hint of why this element is awkward to classify.
Interhalogens: AtI, AtBr and AtCl
Mixing astatine with a lighter halogen gives interhalogen molecules. Astatine monoiodide (AtI), astatine monobromide (AtBr) and astatine monochloride (AtCl) have all been identified, mostly by gas-phase and solution experiments that track how the radioactivity moves.
These are the best-characterized astatine molecules, and even so, bond lengths and dissociation energies often come from calculation rather than measurement. AtI is the one most often discussed, partly because iodine is the natural carrier for astatine and the two form readily.
Higher interhalogens, such as an astatine trifluoride or pentafluoride analog of IF₅, are predicted but not isolated.
Oxygen species and oxidation states
Astatine has more oxidation states than most people expect: -1, +1, +3, +5 and +7 have been reported.
| Species | Formula | Oxidation state | Status |
|---|---|---|---|
| Astatide | At⁻ | -1 | Observed |
| Astatine monoiodide | AtI | +1 | Observed |
| Astatine monobromide | AtBr | +1 | Observed |
| Astatine monochloride | AtCl | +1 | Observed |
| Hypoastatite-type ion | AtO⁻ | +1 | Reported in solution |
| Astatate | AtO₃⁻ | +5 | Observed |
| Perastatate | AtO₄⁻ | +7 | Reported, debated |
| Astatobenzene | C₆H₅At | -1 (bonded to carbon) | Observed |
| Astatine tetrafluoride-type species | AtF₄ and similar | Higher | Predicted only |
Perastatate deserves a caveat. It was first reported in 1968 by oxidizing astatine with xenon difluoride in alkaline solution, and the analogous periodate makes the claim chemically plausible. Later work has treated the identification with more caution than the textbook tables do. For the +5 state, astatate (AtO₃⁻), the evidence is stronger.
Organoastatine compounds
Organoastatine chemistry covers molecules with a carbon-astatine bond. The simplest confirmed example is astatobenzene (C₆H₅At), along with a handful of other aryl and alkyl derivatives.
The problem is the bond. The C-At bond is the weakest carbon-halogen bond you can make in practice, weaker than C-I. In the body, enzymes and oxidizing conditions can snip it, releasing free astatine that goes where free astatine goes (mostly the thyroid, as with iodine). Most organoastatine research is aimed at one question: how do you make a C-At bond that survives long enough to be useful?
Chemists have tried astatine on aromatic rings, on boron cages (which hold the halogen more firmly), and on specialized linkers. None is as sturdy as the equivalent iodine compound.
Astatine vs iodine chemistry
Iodine is the obvious comparison, and astatine follows iodine in many reactions. Both form halide ions, both appear in +1, +5 and +7 oxidation states, and both bond to carbon.
The differences are the interesting part:
- Astatine is more metallic and easier to oxidize, so it forms cations that iodine does not.
- Its single bonds are weaker, particularly to carbon and hydrogen.
- It is much less volatile in some chemical forms, and more volatile in others, depending on oxidation state.
A rule that holds: whatever iodine does, astatine tries it, but with a weaker grip.
Astatine-211 and targeted alpha therapy
The reason anyone funds this work is medical. Astatine-211 emits alpha particles, which deposit large amounts of energy over a distance of only a few cell diameters. In targeted alpha therapy, the isotope is attached to a molecule that seeks out a tumor, so it delivers radiation to cancer cells with limited damage to nearby tissue.
The 7.2-hour half-life suits this use: it is long enough to make, ship and inject, and short enough that the radioactivity is gone within a few days. The catch is attachment. If the label comes off in the bloodstream, the alpha emitter goes with it, which is why the weak C-At bond is the central chemistry problem. Better labeling methods mean better tumor targeting.
Summary
Confirmed astatine chemistry is limited to a few families: astatides (including HAt), interhalogens (AtI, AtBr, AtCl), oxygen anions such as astatate, and carbon-bonded organoastatine compounds like astatobenzene. Several others, including perastatate and higher fluorides, rest on thin experimental evidence or on calculation alone.
The reason the list stays short is physical: a half-life of hours, nano-scale quantities and a bond to carbon that is weaker than iodine’s. The payoff for solving it is practical. Better astatine compounds mean better delivery of astatine-211 in targeted alpha therapy, and the best summary of the field is that astatine behaves like a heavy, metallic cousin of iodine, with fewer certainties. For the basic element data, the PubChem astatine page is a good starting point.
